Long pages

Jump to navigation Jump to search

Showing below up to 50 results in range #51 to #100.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. (hist) ‎Section 1. Introduction (from DOI: 10.3390/v12020211) ‎[4,151 bytes]
  2. (hist) ‎Section 3: Results (from DOI: 10.1016/j.adro.2020.04.015) ‎[3,861 bytes]
  3. (hist) ‎Section 3: Conclusions and priorities for future research (from DOI: 10.1016/j.jcv.2020.104372) ‎[3,855 bytes]
  4. (hist) ‎Section 5. Obstacles to Overcome in the Nearest Future (from DOI: 10.3390/v12020211) ‎[3,852 bytes]
  5. (hist) ‎Wikidata Links ‎[3,850 bytes]
  6. (hist) ‎Section 3.2.7: PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[3,645 bytes]
  7. (hist) ‎Section 4: Viral Toxicity and Myocardial Injury in COVID-2 (from DOI: 10.1007/s11886-020-01292-3) ‎[3,634 bytes]
  8. (hist) ‎Section 3.2.7PI3K/AKT/mTOR signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[3,630 bytes]
  9. (hist) ‎Section 3: Mechanism of SARS-CoV-2 invasion into host cells (from DOI: 10.1016/j.clim.2020.108427) ‎[3,534 bytes]
  10. (hist) ‎Crowdsourcing Bibliography ‎[3,526 bytes]
  11. (hist) ‎Section 5: Immune Responses to SARS-CoV-2 Infection and the Heart (from DOI: 10.1007/s11886-020-01292-3) ‎[3,498 bytes]
  12. (hist) ‎Section 3.2.6: TGF/SMAD signaling pathway in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[3,497 bytes]
  13. (hist) ‎Play Indexing ‎[3,438 bytes]
  14. (hist) ‎Section 2: Methods (from DOI:10.14218/ERHM.2020.00023) ‎[3,318 bytes]
  15. (hist) ‎Section 3.1.1: Myocardial Injury and Heart Failure (from DOI: 10.1007/s11886-020-01293-2) ‎[3,302 bytes]
  16. (hist) ‎Section 1: Introduction (from DOI: 10.1016/j.jcv.2020.104372) ‎[3,284 bytes]
  17. (hist) ‎COVID-19: ICU delirium management during SARS-CoV-2 pandemic ‎[3,274 bytes]
  18. (hist) ‎Section 3.2.9: Interactions between signaling pathways in CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[3,265 bytes]
  19. (hist) ‎Section 4: Discussion (from DOI: 10.1016/j.adro.2020.04.015) ‎[3,207 bytes]
  20. (hist) ‎Section 1: Introduction (from DOI: 10.1007/s11886-020-01292-3) ‎[3,146 bytes]
  21. (hist) ‎Section 1: Introduction (from DOI: 10.1016/j.clim.2020.108427) ‎[3,016 bytes]
  22. (hist) ‎Reading List - Paper I - Bridging Semantic Gap, Etc. ‎[3,001 bytes]
  23. (hist) ‎Section 3.3.7: Exosomes in the TME and CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[2,912 bytes]
  24. (hist) ‎Section 3.3.3: Tumor-associated macrophages and CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[2,851 bytes]
  25. (hist) ‎Need for Caution in the Diagnosis of Radiation Pneumonitis in the COVID-19 Pandemic (DOI: 10.1016/j.adro.2020.04.015) ‎[2,809 bytes]
  26. (hist) ‎Section 6: Host-Specific Variations in COVID-19 Immune Response (from DOI: 10.1007/s11886-020-01292-3) ‎[2,787 bytes]
  27. (hist) ‎Section 3.3.1: Vascular niche microenvironments and CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[2,787 bytes]
  28. (hist) ‎Section 2.2: Congenital and perinatal infections with coronaviruses other than SARS-CoV-2 (from DOI: 10.1016/j.jcv.2020.104372) ‎[2,754 bytes]
  29. (hist) ‎OpenRefine ‎[2,736 bytes]
  30. (hist) ‎Section 5: Conclusions and perspectives (from DOI: 10.1038/s41392-020-0110-5) ‎[2,695 bytes]
  31. (hist) ‎CSR - Directed Study - Summer 2019 ‎[2,680 bytes]
  32. (hist) ‎Section 4.4: CSC-directed immunotherapy (from DOI: 10.1038/s41392-020-0110-5) ‎[2,671 bytes]
  33. (hist) ‎Section 3.3.4: Cancer-associated fibroblasts and CSCs (from DOI: 10.1038/s41392-020-0110-5) ‎[2,631 bytes]
  34. (hist) ‎Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5) ‎[2,562 bytes]
  35. (hist) ‎Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653) ‎[2,504 bytes]
  36. (hist) ‎Computational Thinking ‎[2,448 bytes]
  37. (hist) ‎1992 Alabama Crimson Tide football team ‎[2,370 bytes]
  38. (hist) ‎1961 Alabama Crimson Tide football team ‎[2,370 bytes]
  39. (hist) ‎Introduction section from DOI: 10.1186/s13613-020-00653-z ‎[2,369 bytes]
  40. (hist) ‎Conclusions section from DOI: 10.1186/s13613-020-00653-z ‎[2,369 bytes]
  41. (hist) ‎Discussion section from DOI: 10.1186/s13613-020-00653-z ‎[2,369 bytes]
  42. (hist) ‎Results section from DOI: 10.1186/s13613-020-00653-z ‎[2,369 bytes]
  43. (hist) ‎Methods section from DOI: 10.1186/s13613-020-00653-z ‎[2,369 bytes]
  44. (hist) ‎2017 Alabama Crimson Tide football team ‎[2,359 bytes]
  45. (hist) ‎Human Coronaviruses and the Evidence for Ocular Manifestations (Section from DOI: 10.1080/09273948.2020.1738501) ‎[2,336 bytes]
  46. (hist) ‎Section 3: Results (from DOI:10.14218/ERHM.2020.00023) ‎[2,325 bytes]
  47. (hist) ‎Section 3.3.1. Nucleic Acids Depletion (from DOI: 10.3390/v12020211) ‎[2,322 bytes]
  48. (hist) ‎Feline Coronaviruses and Ocular Manifestations (Section from DOI: 10.1080/09273948.2020.1738501) ‎[2,320 bytes]
  49. (hist) ‎Mouse Coronaviruses and Ocular Implications (Section from DOI: 10.1080/09273948.2020.1738501) ‎[2,317 bytes]
  50. (hist) ‎Introduction (Section from DOI: 10.1080/09273948.2020.1738501) ‎[2,286 bytes]

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

Retrieved from "http://wikibase.slis.ua.edu/wiki/Special:LongPages"